A selective catalytic meta--sulfonation of 2--phenylpyridines was found to occur in the presence of (arene)ruthenium(II) complexes upon reaction with sul--fonyl chlorides. The 2--pyridyl group facilitates the forma--tion of a stable Ru--Caryl σ--bond that induces a strong para directing effect. Electrophilic aromatic substitution pro--ceeds with the sulfonyl chloride to furnish a sulfone in the meta position to the chelating group. This new catalytic process offers access to atypical regioselectivity for reac--tions involving chelation--assisted cyclometallation.
and subsequent sulfonation of 2--phenylpyridine with p--toluenesulfonyl chloride 2a in the presence of six different Ru pre--catalysts (Table 1) . 6 
Scheme 1. Chelation-assisted C-H activation
The initial results were unexpected, as none of the ru--thenium complexes gave the ortho--product upon spectro--scopic analysis of the crude reaction mixtures. Although the conversions were low, the major product isolated from the reaction mixture in all cases was the meta--sulfonation product 3a, the structure of which was unequivocally con--firmed by single crystal X--ray diffraction ( Figure 1 ). 7 In each case the isolated yield reflected the conversion of 2--phenylpyridine 1. As [Ru(p--cymene) Cl2]2 showed the highest level of catalytic activity (Table 1 , entries 1--6) at--tempts were made to increase the isolated yield. After ex--tensive screening, an improved process was realized by simply switching the solvent to CH3CN (Table  1 , entries 6--11). 8 Control experiments showed that no coupling be--tween 1 and 2a took place in the absence of ruthenium (entries 12 and 13). a Unless otherwise noted, the reaction conditions were as follows:
2--phenylpyridine To account for the switch in regioselectivity from Pd to Ru, we hypothesized that the chelating group facilitates the formation of a stable Ru--Caryl σ--bond that induces a strong para directing effect. 9 Substitution of the metallated aro--matic ring proceeds with the sulfonyl chloride to furnish a sulfone in the meta position relative to the original chelat--ing group. To test this hypothesis the cyclometallated Ru--complex 4 was prepared by the literature protocol. 10,6r Treatment of the isolated complex with 3 equiv of p--toluenesulfonyl chloride 2a under the standard reaction conditions (Scheme 2) afforded quantitative conversion to 3a. De--metallation under the reaction conditions would be necessary for catalyst turnover and indeed, when 1 was reacted with 3 equiv of 2a in the presence of a catalytic amount of 4 (10 mol%), the meta--sulfonation product 3a was isolated in 65% yield indicating the likely involvement of Ru--Caryl σ--bond complexes in the catalytic cycle. 11 Al--though the σ--activation of aromatics has been studied for a range of stoichiometric processes such as electrophilic halogenation, acylation and nitration to the best of our knowledge this is the first example of a catalytic σ--activation process. 12 Preliminary experiments with iso--topically labeled starting material showed no evidence of a D/H exchange from adventitious water or solvent. Stop--ping the reaction after 10 hours afforded the metasulfonation product 3a--[D4] in 27% yield along with unre--acted 1--[D5]. 13 A kinetic isotope effect (KH/KD = 3.0) is ob--served suggesting that C--H bond cleavage is kinetically significant in the catalytic cycle.
Scheme 2. Catalytic sulfonation via chelation-assisted σ-activation
We next explored the scope of the ruthenium--catalyzed meta sulfonation (Table  2) . Variation of the sulfonyl chlor--ide afforded a useful range of products in good isolated yields (3b--d and 3f--i). A range of functionality and substi--tution patterns was tolerated. The use of mesitylenesul--fonyl chloride afforded product 3e in lower yield, presum--ably due to the increased steric demands of the two ortho--methyl substituents. Notably, the reaction proceeded with substituents on the aromatic ring (5a and 6a), the chelat--ing pyridine ring (7a and 8a) or both rings (9a). Interest--ingly, the blocking of one of the meta positions on the sub--strate results in no sulfone product (10a) being obtained from the reaction. This substantiates a chelation--assisted σ--activation pathway as presumably the cyclometallation proceeds via the least hindered C--H bond resulting in a complex where the methyl substituent is para to the acti--vating Ru--Caryl σ--bond. With this site blocked no reaction can take place. 9b Table 2 . Scope of ruthenium-catalyzed meta sulfonation a a The reaction conditions were as follows: 2--phenylpyridine 1 (1.0 mmol), arylsulfonylchloride (3.0 mmol), [Ru(p--cymene) Cl2]2 (5 mol %), K2CO3 (2 equiv), CH3CN (3 mL), 115 °C , 15 h. b Isolated yields with mass balance being recovered starting material 1. c X--ray structure obtained. See Supporting Information for details.
The incorporation of a bromo substituent in the product (3g) allows for further synthetic modification utilizing Pd(0)--catalyzed Suzuki--Miyaura cross--coupling and Buchwald--Hartwig amination reactions (Scheme 3). 14, 15 The exemplar reactions proceed in good isolated yield of--fering the capability to access a broader range of functional molecules in just two steps.
In summary, we have a developed a ruthenium--catalyzed sulfonation of 2--phenylpyridines that affords the meta--product. The remarkable switch in regioselectivity implies a change in mechanistic pathway and offers new design principles for reactions involving chelation--assisted cyclometallation. Further work to establish the synthetic scope of catalytic chelation--assisted σ--activation along with additional mechanistic studies is in progress. Scheme 3. Palladium-catalyzed cross-coupling
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